Celestica Inc. (CLS) Stock Analysis
Is CLS a good investment?
Celestica Inc. (CLS) has a Plutrex AI rating of 87.0/100 as of August 19, 2026, indicating a Strong Buy consensus. The stock is not classified as halal-compliant. Key strength: PEG ratio of 0.25 (improved from 0.27 six days ago due to 8.5% price decline) — CLS trades at 25 cents per dollar of growth-adjusted fair value; with 73.6% next-year EPS growth, the P/E of 32.26x compresses to ~18.6x forward within 12 months; analyst consensus target of $466.39 now implies 50.2% upside vs. 37.4% six days ago — the pullback has materially improved the risk-reward. Main concern: Gross margin of 11.6% (65.6% below industry average of 33.5%) remains structurally thin — a 2-3% revenue shortfall would disproportionately compress the 7.16% net margin; hyperscaler CapEx concentration risk persists as a significant portion of revenue is tied to a small number of large customers (Meta, Google, OpenAI, Broadcom); any reduction in AI infrastructure spending could materially impact results; this concern is UNCHANGED from the prior report.
Investment Summary
Celestica (CLS) at $310.59 represents a compelling re-entry opportunity after an 8.5% pullback from the prior report's price of $339.46, restoring the margin of safety that had narrowed. The investment thesis is anchored by a PEG ratio of 0.25 — the stock trades at 25 cents per dollar of growth-adjusted fair value — against a backdrop of 73.6% next-year EPS growth validated by 74.2% historical earnings growth and 62.4% revenue growth. The P/E of 32.26x compresses to approximately 18.6x on a forward basis within 12 months, making this one of the cheapest high-growth names in the market. ROE of 52.7% (399% above the industry average of 10.55%) is achieved with conservative D/E of 0.37, confirming operational excellence rather than financial engineering. FCF of $729M and cash of $537M provide a fortress balance sheet. The analyst consensus target of $466.39 implies 50.2% upside from current price — materially better than the 37.4% implied 6 days ago. News sentiment of 83/100 with 13 positive articles confirms AI infrastructure demand acceleration. The 8.5% price decline with zero fundamental deterioration is the textbook definition of a better entry point on an unchanged thesis.
Key Strengths
- PEG ratio of 0.25 (improved from 0.27 six days ago due to 8.5% price decline) — CLS trades at 25 cents per dollar of growth-adjusted fair value; with 73.6% next-year EPS growth, the P/E of 32.26x compresses to ~18.6x forward within 12 months; analyst consensus target of $466.39 now implies 50.2% upside vs. 37.4% six days ago — the pullback has materially improved the risk-reward
- AI infrastructure demand acceleration confirmed across multiple independent sources — news sentiment of 83/100 with 13 positive articles; strong demand in AI infrastructure segment with positive earnings revision momentum in data centers, aerospace, and industrial sectors; new contract wins with OpenAI and Broadcom (beyond existing Meta and Google partnerships) directly address hyperscaler concentration risk
- ROE of 52.7% (399% above industry average of 10.55%) with conservative D/E of 0.37 (25% below industry average), $537M cash, and $729M FCF — elite capital efficiency with conservative leverage; revenue growth of 62.4% and earnings growth of 74.2% YoY provide high-confidence validation of forward projections; operating margin of 9.82% is 148% above the industry average of 3.96%
Key Concerns
- Gross margin of 11.6% (65.6% below industry average of 33.5%) remains structurally thin — a 2-3% revenue shortfall would disproportionately compress the 7.16% net margin; hyperscaler CapEx concentration risk persists as a significant portion of revenue is tied to a small number of large customers (Meta, Google, OpenAI, Broadcom); any reduction in AI infrastructure spending could materially impact results; this concern is UNCHANGED from the prior report
- Sustaining 63.9% annualized EPS growth over five years requires approximately 10-11x EPS compounding from the current base — an extraordinarily high execution bar; while the 8.5% price decline has improved the margin of safety (entry midpoint now $308 vs. $333.50 prior), any material miss on the 73.6% next-year EPS growth projection would compress the PEG-based valuation thesis and could trigger multiple compression given P/B of 14.40x
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
CLS operates as a contract electronics manufacturer with structurally thin but efficiently managed margins: gross margin of 11.6% (65.6% below the industry average of 33.5%, structural to the business model), operating margin of 9.82% (147.98% ABOVE the industry average of 3.96%), and net margin of 7.16% (vs. industry average of -15.72% — the peer group loses money on average). The P/E of 32.26x (down from 35.26x six days ago due to the 8.5% price decline) is deceptively cheap given 73.6% next-year EPS growth — the implied forward P/E is approximately 18.6x. PEG of 0.25 (down from 0.27) is the most critical metric: at one-quarter of growth-justified fair value, CLS is deeply undervalued. ROE of 52.7% vs. industry average of 10.55% (399% premium) with D/E of only 0.37 (25% below industry average of 0.497) confirms returns are operationally driven. Revenue growth of 62.4% YoY (146% above industry average of 25.34%) and earnings growth of 74.2% YoY validate forward projections of 63.9% 5-year EPS CAGR. FCF of $729M and cash of $537M provide exceptional liquidity. The P/B of 14.40x is elevated but mathematically justified by the 52.7% ROE. Analyst consensus target of $466.39 implies 50.2% upside — the widest gap since coverage began.
News Sentiment
Celestica's stock has become one of Wall Street's most talked-about bargains in the AI infrastructure boom — and for good reason. The Canadian electronics manufacturer, which builds the hardware backbone for artificial intelligence data centers, has seen its shares slide roughly 31% from their highs, creating what analysts are calling a rare buying opportunity in a company with exceptional fundamentals. Wall Street is taking notice. Bank of America recently flagged Celestica among 16 'knocked-down' AI stocks it sees as bargains — a significant endorsement from one of the Street's most influential research teams. Separately, analysts are nearly unanimous in their optimism: a recent headline asked 'Is Celestica a Buy as Wall Street Analysts Look Optimistic?' — and the answer from most is a resounding yes, with a consensus price target of $466.39 implying roughly 50% upside from current levels. The company's AI infrastructure segment is experiencing what analysts describe as 'strong traction,' with demand from hyperscalers like Meta, Google, and newer partners OpenAI and Broadcom showing no signs of slowing. Positive earnings revision momentum — meaning analysts keep raising their forecasts — signals that Celestica's customers are spending more, not less, on the AI hardware it manufactures. One key debate on Wall Street is how Celestica stacks up against networking giant Arista Networks — a recent comparison piece asked 'CLS vs. ANET: Which AI Stock Offers the Better Growth Opportunity?' — with Celestica's dramatically lower valuation (PEG of 0.25 vs. Arista's premium multiple) making a compelling case for the contract manufacturer. For investors willing to look past short-term volatility, the pullback may be the entry point they've been waiting for.
Risk Assessment
PRIMARY RISK: Hyperscaler CapEx deceleration — if Meta, Google, or OpenAI reduce AI infrastructure spending, CLS revenue could miss materially; the thin 11.6% gross margin means a 2-3% revenue shortfall compresses net margin disproportionately. MITIGATION: New contract wins with OpenAI and Broadcom diversify the customer base; positive earnings revision momentum suggests near-term demand is intact. SECONDARY RISK: Growth deceleration — sustaining 63.9% 5-year EPS CAGR from a large base is mathematically demanding; any guidance cut would compress the PEG thesis rapidly. MITIGATION: Historical track record (revenue +62.4%, earnings +74.2%, EPS +72.4% YoY) validates forward projections; FCF of $729M provides buffer. TECHNICAL RISK: Stock is 31% off highs and has declined 8.5% in 6 days — momentum is negative short-term; could test $290-$295 support before recovering. MITIGATION: Entry range low of $298 provides buffer to key support; stop loss at $275 (~10.7% below entry midpoint) limits downside. MACRO RISK: Broader AI sector correction (referenced in news) could create further near-term pressure. MITIGATION: Bank of America identifying CLS as a bargain in knocked-down AI stocks suggests institutional support at current levels.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is CLS a halal stock?
No, Celestica Inc. (CLS) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for CLS?
Celestica Inc. (CLS) has a Plutrex AI rating of 87.0/100 with a Strong Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is CLS a good investment?
According to Plutrex AI, CLS has a Strong Buy rating (87.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in CLS?
US stocks like CLS can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in CLS?
Plutrex AI identifies the main risks for CLS by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.